These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 16321429

  • 1. Small cell of the ovary, hypercalcemic type -- analysis of combined experience and recommendation for management. A GCIG study.
    Harrison ML, Hoskins P, du Bois A, Quinn M, Rustin GJ, Ledermann JA, Baron-Hay S, Friedlander ML.
    Gynecol Oncol; 2006 Feb; 100(2):233-8. PubMed ID: 16321429
    [Abstract] [Full Text] [Related]

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 3. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT, Calaminus G, Wessalowski R, Pathmanathan R, Harms D, Göbel U.
    Klin Padiatr; 2002 Mar 15; 214(4):173-8. PubMed ID: 12165898
    [Abstract] [Full Text] [Related]

  • 4. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
    Dusenbery KE, Bellairs EE, Potish RA, Twiggs LB, Boente MP.
    Gynecol Oncol; 2005 Feb 15; 96(2):307-13. PubMed ID: 15661213
    [Abstract] [Full Text] [Related]

  • 5. Ovarian small cell carcinoma of the hypercalcemic type in children and adolescents: a prognostically unfavorable but curable disease.
    Distelmaier F, Calaminus G, Harms D, Sträter R, Kordes U, Fleischhack G, Göbel U, Schneider DT.
    Cancer; 2006 Nov 01; 107(9):2298-306. PubMed ID: 16998935
    [Abstract] [Full Text] [Related]

  • 6. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E, Deavers MT, Silva EG, Malpica A.
    Am J Surg Pathol; 2007 May 01; 31(5):774-82. PubMed ID: 17460463
    [Abstract] [Full Text] [Related]

  • 7. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM, Moore KN, Myers TK, Lanneau GS, McMeekin DS, Walker JL, Gold MA.
    Gynecol Oncol; 2009 Feb 01; 112(2):337-41. PubMed ID: 19041126
    [Abstract] [Full Text] [Related]

  • 8. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
    Goldberg H, Miller RC, Abdah-Bortnyak R, Steiner M, Yildiz F, Meirovitz A, Villà S, Poortmans PM, Azria D, Zidan J, Ozsahin M, Abacioglu U, Gold DG, Amit A, Lavie O, Atahan IL, Kuten A, Rare Cancer Network.
    Gynecol Oncol; 2008 Feb 01; 108(2):298-305. PubMed ID: 18096209
    [Abstract] [Full Text] [Related]

  • 9. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F, Hasanzadeh M, Karimi Zarchi M, Fallahi A.
    Int J Surg; 2008 Oct 01; 6(5):382-6. PubMed ID: 18715834
    [Abstract] [Full Text] [Related]

  • 10. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG, Gershenson DM, Malpica A, Deavers M.
    Am J Surg Pathol; 2006 Nov 01; 30(11):1367-71. PubMed ID: 17063075
    [Abstract] [Full Text] [Related]

  • 11. Uterine papillary serous carcinoma: patterns of failure and survival.
    Wang W, DO V, Hogg R, Wain G, Brand A, Bull C, Stenlake A, Gebski V.
    Aust N Z J Obstet Gynaecol; 2009 Aug 01; 49(4):419-25. PubMed ID: 19694700
    [Abstract] [Full Text] [Related]

  • 12. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J.
    Oral Oncol; 2008 Jan 01; 44(1):23-30. PubMed ID: 17306611
    [Abstract] [Full Text] [Related]

  • 13. Whole abdominal radiotherapy following second-look laparotomy for ovarian carcinoma.
    MacGibbon A, Bucci J, MacLeod C, Solomon J, Dalrymple C, Firth I, Carter J.
    Gynecol Oncol; 1999 Oct 01; 75(1):62-7. PubMed ID: 10502427
    [Abstract] [Full Text] [Related]

  • 14. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF, Yang QY, Zhen ZJ, Xia Y, Huang ZH, Ling JY.
    Ai Zheng; 2006 Dec 01; 25(12):1529-32. PubMed ID: 17166380
    [Abstract] [Full Text] [Related]

  • 15. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC, Seidman JD, McBroom JW, MacKoul PJ, Aye LM, Rose GS.
    Gynecol Oncol; 2001 Oct 01; 83(1):89-94. PubMed ID: 11585418
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM.
    Cancer; 2009 Sep 15; 115(18):4156-66. PubMed ID: 19551884
    [Abstract] [Full Text] [Related]

  • 17. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA, Partipilo V, Mele F, Boscia F, De Marzo P.
    Minerva Ginecol; 2009 Feb 15; 61(1):1-12. PubMed ID: 19204656
    [Abstract] [Full Text] [Related]

  • 18. A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features.
    Kim BK, Cho BC, Choi HJ, Sohn JH, Park MS, Chang J, Kim SK, Kim DJ, Chung KY, Lee CG, Kim JH, Yoo NC.
    Oncol Rep; 2008 Jun 15; 19(6):1525-31. PubMed ID: 18497960
    [Abstract] [Full Text] [Related]

  • 19. Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes.
    Uzan C, Morice P, Rey A, Pautier P, Camatte S, Lhommé C, Haie-Meder C, Duvillard P, Castaigne D.
    Ann Surg Oncol; 2004 Jul 15; 11(7):658-64. PubMed ID: 15197013
    [Abstract] [Full Text] [Related]

  • 20. [Radiotherapy in tubal carcinomas].
    Schäfer U, Micke O, Witteler R, Willich N.
    Strahlenther Onkol; 1996 Apr 15; 172(4):205-10. PubMed ID: 8623083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.